Leaflet BREVIBLOC 100mg / 10ml solution for infusion


Indicated for: cardiac arrhythmias

Substance: esmolol (beta blocker)

ATC: C07AB09 (Cardiovascular system | Beta blocking agents | Beta blocking agents, selective)

Esmololum is a medication used for the treatment of supraventricular tachycardia and acute hypertension, particularly in emergency situations. It is a cardioselective beta-blocker with rapid action, reducing heart rate and blood pressure.

The medication is administered via intravenous infusion under medical supervision, and the dosage is adjusted based on the patient's response.

Common side effects include hypotension, bradycardia, dizziness, and nausea. In rare cases, more severe adverse effects such as heart failure or bronchospasm may occur.

Esmololum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about BREVIBLOC 100mg / 10ml

  • Substance: esmolol
  • Date of last drug list: 01-05-2026
  • Commercial code: W70514001
  • Concentration: 100mg / 10ml
  • Pharmaceutical form: solution for infusion
  • Quantity: 5
  • Product type: generic
  • Price: 199.82 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BAXTER S.A. - BELGIA
  • Holder: FARMACEUTICA REMEDIA DISTRIBUTION&LOGISTICS S.R.L. - ROMANIA
  • Number: 954/2024/01

Concentrations available for esmolol

  • 100mg/10ml
  • 10mg/ml